A carregar...
Onset of action of indacaterol in patients with COPD: Comparison with salbutamol and salmeterol-fluticasone
BACKGROUND: Indacaterol is a novel, inhaled once-daily ultra-long-acting β(2)-agonist for the treatment of chronic obstructive pulmonary disease (COPD). OBJECTIVES: This study compared the onset of action of single doses of indacaterol 150 and 300 μg with salbutamol 200 μg, salmeterol-fluticasone 50...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2939686/ https://ncbi.nlm.nih.gov/pubmed/20856830 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|